AstraZeneca granted orphan status for pulmonary fibrosis treatment
AstraZeneca granted orphan status for pulmonary fibrosis treatment The FDA granted orphan status for saracatinib, the company's treatment of idiopathic pulmonary fibrosis. https://thefly.com/landingPageNews.php?id=2877903
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.